Dr Reginald Seeto

Vice President, Head of Partnering & Strategy MedImmune

Dr Seeto joined the MedImmune team in 2008, and has held a number of leadership positions with the company during his tenure.  In 2013, he assumed his current role on MedImmune’s executive team, in which he formed, and now leads, the company’s Partnering and Strategy Department.  This group is responsible for devising and executing MedImmune’s external partnership strategy, including business development activities – from M&A and licensing to co-development, joint ventures and out-licensing - along with academic, government and non-profit collaborations and alliances to support all of MedImmune’s biologics and therapy area strategies. Seeto originally joined MedImmune as Vice President of Global Strategic Marketing and Portfolio Management where he worked closely with the R&D leadership team. He was later promoted to MedImmune’s executive team, as EVP of the Corporate Development and Strategy Group, which included the following departments: business development, corporate strategy, corporate projects, MedImmune Ventures and portfolio management. Prior to MedImmune, Seeto was Vice President of Global Marketing for Schering Plough/Organon Biosciences and Executive Director of US Marketing for Boehringer Ingelheim Pharmaceuticals. Earlier in his career he was a consultant at McKinsey & Company and started his career as a medical doctor involved in both clinical practice and research.